The Uncertain Path Forward for Psychedelic Medicine

The Uncertain Path Forward for Psychedelic Medicine

But psychedelic compounds are tricky to test in this way because their psychedelic effects are so recognizable to those who take them. In the Lykos trials, around 90 percent of the participants were able to correctly guess whether they received MDMA or a placebo, effectively “unblinding” the study. If participants knew they received MDMA, they … Read more

The FDA Just Rejected a Bid for MDMA’s Approval to Treat PTSD

The FDA Just Rejected a Bid for MDMA’s Approval to Treat PTSD

The US Food and Drug Administration has rejected a first-of-its-kind proposal to use the psychedelic drug MDMA, also known as ecstasy or Molly, as a treatment for post-traumatic stress disorder. Drugmaker Lykos Therapeutics had asked the FDA to approve the drug in combination with talk therapy. The company said Friday that the regulatory agency has … Read more

They Had PTSD. A Psychedelic Called Ibogaine Helped Them Get Better

They Had PTSD. A Psychedelic Called Ibogaine Helped Them Get Better

After multiple deployments with the US Army Special Forces, Joe Hudak returned home in 2011 changed by his time in Iraq, Afghanistan, and South America. He was quickly diagnosed with post-traumatic stress disorder. He tried talk therapy and a range of medications, but they didn’t help. He attempted suicide twice in 2012. “I was fighting … Read more